geneous affinity and association constant of 4.7 x 103 M-1; and no significant mutual interference of the binding sites seems to exist.
From the results of neothramycin's interaction with various polynucleotides, it was suggested that a guanine base and a double helix conformation of DNA are required for binding the antibiotic.
The current results and previous ones, concerning neothramycin-2'-deoxyguanosine adduct formation, suggested that the antibiotic reacts with 2-amino group of guanine base of DNA by dehydration in the manner of a bimolecular (Sn2ca) equilibrium reaction.
Neothramycin'
is a new antibiotic of the pyrrolo(1,4)benzodiazepine group, and shows potent antitumor effects on experimental neoplasms, particularly sarcoma 180 and Walker tumor 256. The tumor-inhibitory activity of neothramycin seems to be similar to those of other pyrrolo(1,4)benzodiazepine antibiotics, but the toxicity is lower than the others').
We have studied the mechanism of action of neothramycin, and observed that the antibiotic binds to double stranded DNA and shows a preferential block of RNA synthesis over DNA synthesis in vivo and in vitro3•°>. Studies on the structure-activity relationship of neothramycin derivatives have suggested that neothramycin may covalently bind to DNA through C-11').
We have also investigated the interaction of the antibiotic with deoxynucleotides as a model of the drug-DNA binding, and found that the antibiotic selectively reacts with 2'-deoxyguanosine in aqueous dimethyl sulfoxide. The major reaction product has been isolated, and the structure has been determined. It is a one-to-one adduct of neothramycin and 2'-deoxyguanosine, and a covalent aminal bond is formed between C-3 of the antibiotic and N-2 of 2'-deoxyguanosine by dehydration'). Since the fluorescence intensity of neotlira mycin or tomaymycin is greatly enhanced by double stranded DNA, we have examined the binding characteristics of neothramycin to DNA by fluorescence spectroscopy, and the results are presented in this publication. From the current results and previous studies on the reaction with 2'-deoxyguanosine, the reaction mechanism of neothramycin with DNA is proposed. 
Materials and Methods

DNA Solution
Calf thymus DNA was dissolved at a concentration of ca. 1 mg/ml in an aqueous medium, containing 50 mM NaCl and 10 mM disodium EDTA; and dialyzed overnight at 7°C against 50-fold volume of the same medium with subsequent dialysis against 50 mM NaCI solution. It was stored at 2°C. DNA concentrations were assayed as inorganic phosphate by the method of AMES°). Heat-denatured DNA was prepared by heating at 100°C for 5 minutes in a water bath, and then immediately chilled in an ice-bath.
Fluorescence Spectroscopy Corrected and uncorrected fluorescence spectra were recorded on a Hitachi spectrophotofluorometer model MPF-4, equipped with a data processor and a Hitachi 057 X-Y recorder. All measurements were carried out in a cuvette with 1-cm light path at an angle of 90° to excitation beam. The temperature of the sample compartment was controlled to _i' 0.5°C by a Sharp TE-12 circulating bath.
The fluorescence quantum yield was calculated by comparing the absorbance at the excitation wavelength (316 nm) and the emission spectrum of an unknown sample with those of a standard of known quantum yield. Quinine, dissolved in I N LSO, (quantum yield 0.55) was used as a standard').
In kinetic experiments, the reaction was initiated by the addition of a small volume of antibiotic solution to a cuvette, containing DNA solution. The cuvette was kept in the temperature-controlled sample-compartment for at least 10 minutes prior to the drug addition.
Fluorescence Intensity of Neothramycin-DNA Complex Since a fraction of neothramycin always remained unbound to DNA, using fluorometrically detectable concentrations of the antibiotic and soluble concentrations of DNA, the fluorescence intensity of neothramycin-DNA complex was calculated by the equation (7) (2) is expressed by
Assuming that the fluorescence increase parallels the amount of bound neothramycin, equations (4) and (5) where [At] is a total concentration of free and bound neothramycin, JF the increase of neothramycin fluorescence by the presence of DNA, and JF,,,,,, the fluorescence intensity of neothramycin-DNA complex, from which that of free neothramycin was subtracted.
Substituting (4) and (5) into (3), equation (6) is obtained. 
By plotting I/JF on the vertical axis and 1/[P] on the horizontal axis, l/JF,, value is obtained as an intercept on the vertical axis (cf. Fig. 4 ).
[Ab] and [AF] can be calculated by equations (4) and (5), using JF and JF,,,a, values.
Moreover, the equation (2) can be rearranged to give equation (8) .
[Af]
[P1 (8) The plots The fluorescence intensity of neothramycin was enhanced, and a little blue shift of the emission 2,,,-was observed by the presence of native calf thymus DNA; the degrees of fluorescence increase were dependent upon DNA concentrations (Fig. 3) .
Using the equation (7) described in Materials and Methods, the relative fluorescence increase of neothramycin by the presence of DNA in a range of DNA concentrations (100 1,000 !cN' P) were obtained (Fig. 4) . In the case of tomaymycin, the antibiotic completely bound to excess DNA, and the relative fluorescence strength of the drug-DNA complex was found to be 3.0 fold to that of free tomaymycin at the same concentration. The amounts of neothramycin bound to DNA were calculated from the fluorescence intensity increase (dF) over a range of concentrations of neothramycin (1 100 ,uM) and DNA. P (100 1,700 fLM) 
4F:
The increase of neothramycin fluorescence. Reaction Characteristics of Neothramycin and DNA As presented in Fig. 7 , the reaction rate of neothramycin with DNA was slower than that of tomaymycin, suggesting that neothramycin shows the slowest reaction rate with DNA in the pyrrolo-(1,4)benzodiazepine group of antibiotics. The reaction rate of neothramycin with DNA was dependent upon both drug and DNA concentrations (Fig. 8) .
The binding rate of neothramycin to DNA was highly dependent upon pH of the buffer used, and markedly promoted by hydrogen ion (H+) in a range of pH 5 N 7 (Fig. 9 ). There appeared to exist a linear relationship between the initial reaction rate constants and pH of the buffer (Fig. 10) . However, the reaction rate was not significantly changed in a concentration range of ION 100 mM NaCI in 5 mM TES-KOH buffer, pH 7.0 containing 1.5 mM EDTA. The interactions of neothramycin with nucleic acid and synthetic deoxynucleotides were studied by fluorospectrometry, and the results are summarized in The covalent bond formation between the antibiotic and DNA has been suggested4 ,5) .
More intensive interaction of neothramycin with poly[dG-dC] than poly[dI-dC] and poly[dA-dT] suggests that 2-amino group of guanine base of DNA participates in the binding to DNA. The same base specificity has been found in the reaction with 2'-deoxynucleosides5).
Most substances (proflavine, quinacrine etc.) show decrease of fluorescence intensity by binding to DNA, but some (ethidium bromide, acridine orange, etc.) show an increase18-18). Since the fluorescence is derived from the benzene ring of neothramycin, the benzene ring moiety may bind to DNA presumably by hydrogen bonding. However, the mechanism of fluorescence increase of neothramycin by DNA remains to be determined.
The fluorescence intensity and emission Amax of the neothramycin-DNA complex are similar to those of the drug in ethanol and methanol, but differ from those in dichloromethane or ethyl acetate, suggesting that the antibiotic exists in the neighborhood of the phosphate-sugar backbone of DNA.
The reaction rate of pyrrolo(1,4)benzodiazepine antibiotics with DNA is slower than those of mitomycin C, actinomycin D and adriamycin8). Of the pyrrolo(1,4)benzodiazepine group, neothramycin exhibits the slowest reaction rate with DNA. Anthramycin, sibiromycin and tomaymycin possess unsaturated side chains at C-2, which may participate in the binding to DNA8). The absence of a C-2 side chain in the neothramycin molecule may be related to the slow reaction rate with DNA. The lower toxicity of neothramycin than the other pyrrolo(1,4)benzodiazepines might be due to the slower binding rate to DNA.
The reaction of neothramycin to DNA is catalyzed by hydrogen ion. Since the acid-base balance tends to be more acidic direction in cancer cells than in normal cells17,18),, neothramycin may bind to DNA more intensively in the tumor cells than in normal cells.
Neothramycin possesses carbinolamines at 3,4-and 10,11-positions : both may be chemically reactive in a similar manner. We have observed that the antibiotic may bind to DNA mainly through C-11 and to 2'-deoxyguanosine through C-34,1). Both C-i I and C-3 may possess a potential reactivity with DNA. However, the steric hindrance of, and/or hydrogen bond formation with the double helix of DNA may lead to the complex formation through the C-11 more easily than through the C-3.
The reaction of neothramycin with DNA is similar to that with 2'-deoxyguanosine in the following characteristics: (1) slow reaction rate, (2) specificity for guanine base, (3) catalysis by hydrogen ion, (4) dependency on both drug and nucleotide concentrations, and (5) reversible reaction. Since the mechanism, therefore, seems to be similar in both reactions, the formation of neothramycin-DNA complex may involve the nucleophilic attack originating from 2-amino group of DNA guanine at C-11 of the antibiotic and dehydration and may be a bimolecular substitution reaction, catalyzed by hydrogen ion. Since most 2-amino groups of guanine are exposed to the narrow groove of DNA, neothramycin may be bound within the minor groove of the double helix. This is in accord with the reports by GLAUBIGER et al.a) and by HURLEY et al. 19, 20) . HURLEY8) has assumed that the interaction of pyrrolo(1,4)benzodiazepine antibiotics with DNA occurs in at least two steps : the first being a non-covalent type of interaction and the second covalent attachment : 
